BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18797063)

  • 21. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
    de Jong EM; Mørk NJ; Seijger MM; De La Brassine M; Lauharanta J; Jansen CT; Guilhou JJ; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber MR; Van De Kerkhof PC
    Br J Dermatol; 2003 Feb; 148(2):318-25. PubMed ID: 12588386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate.
    Homsi S; Alexandrescu DT; Milojkovic N; Abouzgheib W; Bachour K; Homsi Y; Dasanu CA
    Dermatol Online J; 2010 May; 16(5):1. PubMed ID: 20492818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
    Langman G; Hall PM; Todd G
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
    Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
    Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe 20-nail psoriasis successfully treated by low dose methotrexate.
    Lee JY
    Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
    Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
    Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis.
    Takeyama J; Sato A; Nakano K; Abukawa D; Ichinohazama R; Imaizumi M
    J Pediatr Hematol Oncol; 2006 Sep; 28(9):622-4. PubMed ID: 17006270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.
    Haustein UF; Rytter M
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):382-8. PubMed ID: 11305380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC; Menter MA
    J Am Acad Dermatol; 2004 Feb; 50(2):301-9. PubMed ID: 14726893
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.
    Chiaravalloti AJ; Strober BE
    J Drugs Dermatol; 2014 Aug; 13(8):929-31. PubMed ID: 25116970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis.
    Affleck A; Goudie A; Smith R
    Clin Exp Dermatol; 2019 Jul; 44(5):591-592. PubMed ID: 30919996
    [No Abstract]   [Full Text] [Related]  

  • 33. Nail psoriasis successfully treated with intralesional methotrexate: case report.
    Sarıcaoglu H; Oz A; Turan H
    Dermatology; 2011 Feb; 222(1):5-7. PubMed ID: 21228554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary lymphoma developed during long-term methotrexate therapy for psoriasis.
    Suzuki M; Hirano S; Ito H; Matsubara D; Kubota K; Takeda Y; Sugiyama H; Kobayashi N; Kudo K
    Respirology; 2007 Sep; 12(5):774-6. PubMed ID: 17875071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease.
    Moseley AC; Lindsley HB; Skikne BS; Tawfik O
    J Rheumatol; 2000 Mar; 27(3):810-3. PubMed ID: 10743830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate.
    Yildirim Y
    Gynecol Oncol; 2005 Apr; 97(1):249-52. PubMed ID: 15790469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermittent, short term use of methotrexate for exacerbations of psoriasis.
    Clark AR; Feldman SR
    Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab-induced remission of extensive plaque psoriasis.
    Amital H; Ingber A; Rubinow A
    Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.